Integra Lifesciences Holdings (IART) Tax Rate (2009 - 2026)
Integra Lifesciences Holdings (IART) reported Tax Rate of 91.66% for Q1 2026, down 10745.0% on a YoY basis from N/an in Q1 2025, and down 165.69% sequentially from 139.54% in Q4 2025.
Integra Lifesciences Holdings (IART) Tax Rate (2009 - 2026) Analysis & Trends
Integra Lifesciences Holdings (IART) has 18 years of Tax Rate data on file, last reported at 91.66% in Q1 2026.
- For the quarter ending Q1 2026, Tax Rate fell 10745.0% year-over-year to 91.66%; the trailing twelve-month figure through Mar 2026 stood at 7.48% (down 2525.0% YoY), and the FY2025 full-year result was 8.35%, down 5358.0% from the prior year.
- Tax Rate eased to 91.66% in Q1 2026, from 139.54% in the prior quarter.
- In the past five years, Tax Rate ranged from a high of 139.54% in Q4 2025 to a low of 91.66% in Q1 2026.
- A 5-year average of 18.12% and a median of 16.31% in 2022 frame the typical range for Tax Rate.
- Across the five-year window, Tax Rate jumped 12576 bps in 2025 and sank 10745 bps in 2026, its largest moves.
- Tracing IART's Tax Rate over 5 years: stood at 17.54% in 2022, then soared by 78 bps to 31.27% in 2023, then sank by 56 bps to 13.78% in 2024, then surged by 913 bps to 139.54% in 2025, then slumped by 166 bps to 91.66% in 2026.
- Business Quant data shows IART's Tax Rate at 91.66% in Q1 2026, 139.54% in Q4 2025, and 20.81% in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Tax Rate (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 25.67% |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 12.35% |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 31.35% |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | -15.15% |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 17.06% |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 25.97% |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | -23.16% |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 18.61% |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Integra Lifesciences Holdings | 1.71 Bn | 1.45 Bn | 216.98 Mn | -91.66% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -91.66% |
| Mar 31, 2026 | -91.66% |
| Mar 31, 2026 | -91.66% |
| Dec 31, 2025 | 139.54% |
| Dec 31, 2025 | 139.54% |
| Dec 31, 2025 | 139.54% |
| Sep 30, 2025 | 20.81% |
| Sep 30, 2025 | 20.81% |
| Sep 30, 2025 | 20.81% |
| Jun 30, 2025 | 8.83% |
| Jun 30, 2025 | 8.83% |
| Jun 30, 2025 | 8.83% |
| Mar 31, 2025 | 15.79% |
| Mar 31, 2025 | 15.79% |
| Mar 31, 2025 | 15.79% |
| Dec 31, 2024 | 13.78% |
| Dec 31, 2024 | 13.78% |
| Dec 31, 2024 | 13.78% |
| Sep 30, 2024 | 47.48% |
| Sep 30, 2024 | 47.48% |